Source comparison
Ipamorelin Review 2026: Dosing & Timing Comparison
Protocol timing and dosing structure determine GH pulse quality and receptor longevity. This table compares common administration patterns based on clinical evidence and real-world application data. Single Daily Dose 200–300mcg Pre-sleep only 15–20 ng/mL Moder
This comparison does not assign a generated winner or score.
- Protocol timing and dosing structure determine GH pulse quality and receptor longevity. This table compares common administration patterns based on clinical evidence and real-world application data.
- Single Daily Dose
- 200–300mcg
- Pre-sleep only
- 15–20 ng/mL
- Moderate. Desensitisation by week 10–12
- Simplest compliance but suboptimal pulsatility; best for short cycles or new users
- Twice Daily Split
- 200–300mcg total
- Post-training + pre-sleep
- 18–25 ng/mL per pulse
- High. Sustainable through 12 weeks
- Gold standard for body recomposition and recovery; mimics natural GH rhythm
- Three-Times Daily
- 300mcg total
- Morning, post-training, pre-sleep
- 22–27 ng/mL per pulse
- Very High. Minimal desensitisation through 12 weeks
- Optimal for GH-deficient populations or advanced protocols; requires strict timing
- High-Dose Single Pulse
- 400–500mcg
- 28–35 ng/mL initially, drops to 12–15 ng/mL by week 6
- Poor. Rapid receptor downregulation
- Not recommended; receptor burnout negates initial benefit
- Micro-Dose Continuous
- 50–75mcg
- Four times daily
- 8–12 ng/mL per pulse
- Excellent. No desensitisation observed through 16 weeks
- Experimental; high compliance burden but preserves sensitivity indefinitely